ATHEROSCLEROSIS. Atherosclerosis Atherosclerosis is a disease of large and medium-sized muscular arteries and is characterized by endothelial dysfunction,

Slides:



Advertisements
Similar presentations
Statins as Protective Agents for Aortic Endothelial Cells Robert Kreisberg West Liberty State College.
Advertisements

Preventing Strokes One at a Time Acute Interventions and Management 2009.
Atherosclerosis Mike Clark, M.D.. Terms Arteriosclerosis – hardening of the arteries Atherosclerosis – a form of arteriosclerosis Venosclerosis Arteriolosclerosis.
Pathogenesis of Atherosclerosis Judith Berliner, Ph.D. Departments of Pathology and Medicine Division of Cardiology David Geffen School of Medicine at.
Stents Are Not Enough: Statins Keith Channon Department of Cardiovascular Medicine University of Oxford John Radcliffe Hospital, Oxford.
Low Density Lipoprotein (LDL) LDL derived from VLDL as TAG in VLDL (and IDL) removed by lipoprotein lipase  LDL major cholesterol-carrying lipoprotein.
It’s ALIVE: Atherogenesis, a Dynamic Inflammatory Process Kathy Robinson, PhD, RN, CCNS University of North Florida School of Nursing NTI, New Orleans,
Aging of the Cardiovascular System (continued)
Lipid Metabolism 3: Cholesterol biosynthesis, lipoprotein metabolism, steroid and eicosanoid synthesis Bioc 460 Spring Lecture 37 (Miesfeld) Steroids.
MCB 135K: Discussion.
Types of blood vessels: Veins Arteries Common structures Tunica adventitia Tunica media Tunica intima Lumen.
Atherosclerosis  hardening of the arteries due to the deposition of atheromas  heart disease is the leading cause of death  caused by the deposition.
Goals: 1) Understand the mechanism for ↑LDL in Type II diabetes 2) Having previously established the link between endothelial cell damage (loss of inhibitory.
Kirk Mykytyn, Ph.D. Department of Pharmacology
Lipoprotein Structures, Function and Metabolism (4)
The Biology of Atherosclerosis, Heart Attacks and Strokes
Hyperlipidemia Hyperlipoproteinemia Hyperlipoproteinemia (cholesterol, Triglyceride, LDL-C, VLDL) Lead to atherosclerosis and Coronary artery disease.
Ischaemic Heart Disease (Coronary Artery Disease)
Atherosclerosis Part 1 Atherosclerosis The general term for hardening of the arteries The most prevalent form of atherosclerosis is characterized by the.
03/06/231 K June /06/232 Atherosclerosis Etiology Classic Risk Factors Dyslipidemia Low HDL Epidemiological Studies (e.g. Framingham) Genetic.
ATHEROSCLEROSIS Dr: Wael H.Mansy, MD Assistant Professor
Atherosclerosis CVS lecture 2 Atherosclerosis Shaesta Naseem.
Atherosclerosis CVS 1 Hisham Al Khalidi. Atherosclerosis.wmv.
Note Midterm - 7 March in class. Note Signal peptide-A sequence of amino acids that determine whether a protein will be formed on the rough endoplasmic.
atherosclerosis Jon Yap John A. Burns School of Medicine
Atherosclerosis Atherosclerosis is a specific form of arteriosclerosis (thickening & hardening of arterial walls) affecting primarily the intima of large.
Atherosclerosis CVS lecture 2 Atherosclerosis. Vessel wall structure.
Dr.Hesham Rashid, MD PATHOGENIC MECHANISMS OF ATHEROSCLEROSIS
Cardiovascular Disease
Cardiovascular pathophysiology III
Overview of advanced glycation end-products (AGEs) Part 2
VASCULAR DISEASE Atherosclerosis Jagdish Butany,MBBS,MS,FRCPC, Prof. Dept Lab Med & Pathobiol., Pathologist, UHN-Toronto Gen/Hosp
Drugs Used to Treat Dyslipidemias Chapter 22 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Atherosclerosis Please read Robbins p
ATHEROSCLEROSIS. Institute of Pathological Physiology Martin Vokurka Winter Semester 2007/08.
순환기질환 - 혈관, 림프관 -.
HYPERLIPIDEMIA  Coronary heart disease (CHD) is the cause of about half of all deaths. The incidence of CHD is correlated with elevated levels of low-density.
بسم الله الرحمن الرحيم.
What do I remember? What is thrombosis?
Biochemical Basis of CVD:Part-1 Role of Free radicals & Antioxidants
Cholesterol metabolism
Lipoprotein Structure, Function, and Metabolism
Is atherosclerosis a metabolic disease?
بسم الله الرحمن الرحيم.
Cardiovascular Disease
Peter Libby, MD  The American Journal of Medicine 
Mini Lecture 2 Module: Effects of Tobacco on the Cardiovascular System
Statins induced myopathy
Antilipidaemic agents
Section II: A primer on the endothelium
Section 3: Role of lipids in endothelial function
Ch 13.6: Blood Vessels 13.7: Athrosclerosis and Cardiac Arrhythmias
Focus: Lipids and the endothelium
B. Mechanisms of disease
Section I: RAS manipulation
Arteriosclerosis & Atherosclerosis
Advanced Nutrition Diet and Cardiovascular Disease 1
Hyperlipidemia: A well-documented modifiable risk factor for stroke
Fig 6.1 Drug released by diffusion
Nat. Rev. Cardiol. doi: /nrcardio
Diabetes and atherosclerosis
Section IV: The interaction of the RAS and lipids
Endothelial function: Changing the pattern of treating CV disease
Figure 2 Protective functions of HDL
Atherosclerosis Dr:HAMED ALGHAMDI.
The Biological Role of Inflammation in Atherosclerosis
Macrophages in the Pathogenesis of Atherosclerosis
Impaired Lung Function and Risk for Stroke
Atherosclerosis  Christopher K. Glass, Joseph L. Witztum  Cell 
Christian Rask-Madsen, George L. King  Cell Metabolism 
Presentation transcript:

ATHEROSCLEROSIS

Atherosclerosis Atherosclerosis is a disease of large and medium-sized muscular arteries and is characterized by endothelial dysfunction, vascular inflammation, and the buildup of lipids, cholesterol, calcium, and cellular debris within the intima of the vessel wall. Risk factors are 1. Non modifiable risk factors: Include age, sex, and genetic factors 2. Mxodifiable risk factors: Include Hypertension, Diabetes mellitus, Cigarette smoking, some types of infections, C- Reactive Protein, Homocysteine, Lipoprotein(a), Elevated fibrinogen

DiabetesDiabetes HypertensionHypertension Oxidative stress Endothelial cell injury VasoconstrictionVasoconstriction Erectile dysfunction outcomeoutcome DyslipidemiaDyslipidemia TobaccoTobacco ThrombosisThrombosis AtherosclerosisAtherosclerosis precursorprecursor

Pathogenesis of atherosclerosis Hypotheses of atherogenesis Three distinct hypotheses have emerged that are currently under active investigation. : 1) the response-to-injury, 2) the response-to-retention, and 3) oxidative modification

Modified LDL (ox LDL ) Scavenger R of macrophege Enhance End. Adhesiveness for leukocyte + platelet+ alter local vascular Anticoagulant Endothelial denudation Cytokines, vasoctive agent, G F Inflammation R Migration of SMC into intima Proliferates to form intermediate lesion Macrophage engulf deposited LDL Lipid laden (foam cell ) Necrosis Cytokines, GF and proteolytic enz Lead to Lipoprotein Retention Lipoprotein lipase increase adherence of LDL invitro Micro aggregation Inflammation R Atherosclerosis

Biological Functions of nitric oxide in atherosclerosis Nitric oxide has many physiological actions that can be interpreted to be potentially antiatherosclerotic. It inhibits 1) platelet aggregation and adherence to endothelial cells, 2) monocyte adherence to endothelial cells, 3) the expression of the monocyte chemoattractant protein, 4) vascular smooth muscle cell migration and proliferation and 5) the in vivo intimal proliferative response to ballon injury.

Biological Functions of Nitric Oxide eNOS (Endothelial Nitric Oxide Synthase) is the protein that helps produce NO and is a marker of endothelial cell function

Treatment of atherosclerosis Treatment of atherosclerosis relies heavily on the reduction of risk factors. Lifestyle factors are also of greatest importance in the treatment of atherosclerosis 1-Lifestyle change: Lifestyle changes such as smoking cessation, Regular exercise, Maintenance of appropriate body weight contribute significantly to the treatment of most forms of cardiovascular diseases 2-Medications Medications commonly prescribed in the treatment of atherosclerosis include anti-hypertensives and cholesterol reducing drugs

A.Anti-hypertensives: While anti-hypertensives do not control the process of atherosclerosis, they are successful in controlling one of the primary side effects. These drugs include calcium channel blockers, ACE inhibitors, and angiotensin receptor blockers B. Cholesterol reducing drugs: Keeping serum cholesterol level in the normal range not only helps prevent heart attacks and strokes but may also prevent the progression of atherosclerosis. These drugs include: Statins, Bile-Acid–Binding Resins, Nicotinic Acid, Fibrates, Cholesterol absorption inhibitors (ezetimibe)

Mechanism of action of statins :  nhibition of HMG CoA : Statins inhibit HMG-CoA reductase, the enzyme that converts HMG-CoA into mevalonic acid, a cholesterol precursor (the rate limiting step in cholesterol synthesis)  Statins inhibit hepatic synthesis of apolipoprotein B100 and reduce the synthesis and secretion of triglyceride-rich lipoproteins  Reduction of LDL susceptibility towards oxidation

Pleiotropic effects of statins :  statins plieotropic effects are dissociated from their hypolipidemic effects and these effects include  1- anti inflammatory effects : statins decrease serum level of C-Reactive protien and decrease adhesion and chomotactic molecules  2- immunomodulatory role : statins can decrease T-cell proliferation and reduce inflammatory cytokine production like tumor necrosis factor-α  3- statind improve endothelial dysfunction : by increasin increasing the bioavialability of nitric oxide which has vasodilator, antithrombotic and anti-proliferative properties

 4-statins have antioxidant properties  5- statins stabilizes pleaques and prevent their rupture  6- Statins may impede thrombogenesis by inhibiting the activation of the extrinsic coagulation pathway, by inhibiting platelet adhesion and aggregation  7-Statins have a potential role in regulating the sympathetic and vagal outflow in the central nervous system by enhancing NO synthesis in the endothelium and thus increase the vasodilatory response to acetylcholine and modulate the release and action of vasoconstrictors (e.g.endothelin and angiotensin II)